Should You Buy Ping An Biomedical Co Ltd (PASW) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/26
Ping An Biomedical Co Ltd (PASW) is not a strong buy at this moment for a beginner investor with a long-term strategy. The technical indicators are bearish, there is no significant news or trading trend to support a positive outlook, and no proprietary trading signals are present. Given the lack of positive catalysts and the bearish technical setup, holding off on purchasing this stock is recommended.
Technical Analysis
The MACD is negative and contracting (-0.0166), RSI is neutral at 34.635, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels with resistance at 0.361 and support at 0.15, indicating a bearish trend.
Analyst Ratings and Price Target Trends
No data available for trend analysis or analyst ratings.
Wall Street analysts forecast PASW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PASW is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast PASW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PASW is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0
Current: 0.201
0
Current: 0.201
No data
